Jersey Shore University Medical Center achieves national distinction for lung and esophageal cancer programs

Hackensack Meridian Jersey Shore University Medical Center said it recently earned the Joint Commission’s Gold Seal of Approval – Lung Cancer Accreditation and Esophageal Cancer Accreditation.

The academic medical center was the first in the state to achieve Lung Cancer Accreditation in 2018 and the first and only in the nation to achieve Esophageal Cancer Accreditation. This is the second renewal for Jersey Shore University Medical Center since 2018, when it was awarded both accreditations.

The Gold Seal is a symbol of quality that reflects a health care organization’s commitment to providing safe and high-quality patient care.

“The accreditations speak to our extraordinary cancer and surgical teams and the personalized and innovative care they provide all our patients,” said thoracic surgeon Dr. Thomas Bauer II, chair of surgery and chief of thoracic surgery at Jersey Shore University Medical Center.

The Joint Commission’s standards are developed in consultation with health care experts and providers, measurement experts and patients. They are informed by scientific literature and expert consensus to help health care organizations measure, assess and improve performance. The surveyors also conducted onsite observations and interviews.

Bauer led the team of Joint Commission reviewers during their rigorous, unannounced onsite review earlier this year. The team evaluated the lung cancer and esophageal cancer programs’ compliance with quality standards in such areas as infection prevention and control, environment of care and anesthesia management, among other areas.